Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action.

Xu Q, Si LY.

Nutr Res. 2012 Sep;32(9):648-58. doi: 10.1016/j.nutres.2012.07.002. Epub 2012 Aug 22. Review.

PMID:
23084637
2.

Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.

Chen S, Xiao X, Feng X, Li W, Zhou N, Zheng L, Sun Y, Zhang Z, Zhu W.

J Nutr Biochem. 2012 Sep;23(9):1100-12. doi: 10.1016/j.jnutbio.2011.06.003. Epub 2011 Dec 1.

PMID:
22137261
3.

Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.

Kanamori H, Takemura G, Goto K, Tsujimoto A, Ogino A, Takeyama T, Kawaguchi T, Watanabe T, Morishita K, Kawasaki M, Mikami A, Fujiwara T, Fujiwara H, Seishima M, Minatoguchi S.

Am J Pathol. 2013 Mar;182(3):701-13. doi: 10.1016/j.ajpath.2012.11.009. Epub 2012 Dec 28.

PMID:
23274061
4.

Resveratrol in cardiovascular disease: what is known from current research?

Wang H, Yang YJ, Qian HY, Zhang Q, Xu H, Li JJ.

Heart Fail Rev. 2012 May;17(3):437-48. doi: 10.1007/s10741-011-9260-4. Review.

PMID:
21688187
5.

Resveratrol induces cell apoptosis in adipocytes via AMPK activation.

Chen S, Zhou N, Zhang Z, Li W, Zhu W.

Biochem Biophys Res Commun. 2015 Feb 20;457(4):608-13. doi: 10.1016/j.bbrc.2015.01.034. Epub 2015 Jan 17.

PMID:
25603053
6.

Metabolic effects of resveratrol: addressing the controversies.

Bitterman JL, Chung JH.

Cell Mol Life Sci. 2015 Apr;72(8):1473-88. doi: 10.1007/s00018-014-1808-8. Epub 2014 Dec 30. Review.

PMID:
25548801
7.

The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposus-mediated pain in vitro and in vivo.

Wuertz K, Quero L, Sekiguchi M, Klawitter M, Nerlich A, Konno S, Kikuchi S, Boos N.

Spine (Phila Pa 1976). 2011 Oct 1;36(21):E1373-84. doi: 10.1097/BRS.0b013e318221e655.

PMID:
21587103
8.

Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation.

Lin JN, Lin VC, Rau KM, Shieh PC, Kuo DH, Shieh JC, Chen WJ, Tsai SC, Way TD.

J Agric Food Chem. 2010 Feb 10;58(3):1584-92. doi: 10.1021/jf9035782.

PMID:
19928762
9.

Derivatives of resveratrol: potential agents in prevention and treatment of cardiovascular disease.

Ruan BF, Lu XQ, Song J, Zhu HL.

Curr Med Chem. 2012;19(24):4175-83. Review.

PMID:
22830334
10.

Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.

Kim MY, Lim JH, Youn HH, Hong YA, Yang KS, Park HS, Chung S, Ko SH, Shin SJ, Choi BS, Kim HW, Kim YS, Lee JH, Chang YS, Park CW.

Diabetologia. 2013 Jan;56(1):204-17. doi: 10.1007/s00125-012-2747-2. Epub 2012 Oct 23. Erratum in: Diabetologia. 2013 Mar;56(3):681. Koh, S H [corrected to Ko, S H].

PMID:
23090186
11.

Resveratrol and cardiovascular health.

Das M, Das DK.

Mol Aspects Med. 2010 Dec;31(6):503-12. doi: 10.1016/j.mam.2010.09.001. Epub 2010 Sep 15. Review.

PMID:
20837050
12.

Recent advances in the study on resveratrol.

Nakata R, Takahashi S, Inoue H.

Biol Pharm Bull. 2012;35(3):273-9. Review.

13.

Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.

Turan B, Tuncay E, Vassort G.

J Bioenerg Biomembr. 2012 Apr;44(2):281-96. doi: 10.1007/s10863-012-9429-0. Review.

PMID:
22437738
14.

Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats.

Wan D, Zhou Y, Wang K, Hou Y, Hou R, Ye X.

Brain Res Bull. 2016 Mar;121:255-62. doi: 10.1016/j.brainresbull.2016.02.011. Epub 2016 Feb 11.

PMID:
26876758
15.

Resveratrol in metabolic health: an overview of the current evidence and perspectives.

Poulsen MM, Jørgensen JO, Jessen N, Richelsen B, Pedersen SB.

Ann N Y Acad Sci. 2013 Jul;1290:74-82. doi: 10.1111/nyas.12141. Review.

PMID:
23855468
16.

Up-regulation of endothelial nitric oxide synthase (eNOS), silent mating type information regulation 2 homologue 1 (SIRT1) and autophagy-related genes by repeated treatments with resveratrol in human umbilical vein endothelial cells.

Takizawa Y, Kosuge Y, Awaji H, Tamura E, Takai A, Yanai T, Yamamoto R, Kokame K, Miyata T, Nakata R, Inoue H.

Br J Nutr. 2013 Dec;110(12):2150-5. doi: 10.1017/S0007114513001670. Epub 2013 Jun 11.

PMID:
23750556
17.

Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells.

Lee SJ, Kim MM.

Life Sci. 2011 Mar 14;88(11-12):465-72. doi: 10.1016/j.lfs.2011.01.005. Epub 2011 Jan 14.

PMID:
21238464
18.

Physiological effects of resveratrol.

Kalantari H, Das DK.

Biofactors. 2010 Sep-Oct;36(5):401-6. doi: 10.1002/biof.100. Review.

PMID:
20623511
19.

Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.

Carrizzo A, Forte M, Damato A, Trimarco V, Salzano F, Bartolo M, Maciag A, Puca AA, Vecchione C.

Food Chem Toxicol. 2013 Nov;61:215-26. doi: 10.1016/j.fct.2013.07.021. Epub 2013 Jul 18. Review.

PMID:
23872128
20.

Anti-inflammatory responses of resveratrol.

Das S, Das DK.

Inflamm Allergy Drug Targets. 2007 Sep;6(3):168-73. Review.

PMID:
17897053

Supplemental Content

Support Center